13F Holdings
中文EN

UL UNILEVER PLC IFRS

Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics · NYSE · SEC CIK 217410 · Reporting currency EUR · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-3.8%
TTM net income YoY64.9%
TTM EPS YoY67.4%
Revenue 3-yr CAGR-5.6%
Net income 3-yr CAGR7.4%

Margins

Gross margin46.9%
Operating margin17.9%
Net margin18.7%
FCF margin13.7%
EBITDA margin20.5%

Returns

ROE53.3%
ROA12.6%
ROIC (approx.)50.8%
Asset turnover0.67x

Leverage & solvency

Liabilities / assets75.0%
Debt / equity0.00x
Current ratio0.79x
Interest coverage8.83x

Cash quality & payout

Operating cash flow / net income0.88x
Accruals ratio1.5%
Payout ratio47.0%
Capex / revenue2.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Unit: EUR FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue50.50B52.48B51.68B60.07B52.44B
Cost of revenue26.79B27.98B29.18B35.91B30.26B
Gross profit23.71B24.50B22.50B24.17B22.18B
R&D expense836.00M892.00M853.00M908.00M847.00M
SG&A expense13.62B14.30B13.42B14.48B12.55B
Operating income9.04B8.83B9.00B10.76B8.70B
Interest expense1.02B994.00M922.00M818.00M491.00M
Pretax income8.69B8.37B8.63B10.34B8.56B
Income tax2.48B2.33B1.99B2.07B1.94B
Net income9.47B5.74B6.49B7.64B6.05B
EBITDA10.35B10.07B10.14B12.48B10.45B
EPS (basic)4.332.592.903.002.33
EPS (diluted)4.322.582.892.992.32
Weighted avg. shares (diluted)2.20B2.23B2.25B2.56B2.61B
Balance sheet
Cash & equivalents3.94B6.14B4.16B4.33B3.42B
Receivables7.35B6.01B5.78B7.06B5.42B
Inventory4.04B5.18B5.12B5.93B4.68B
Current assets17.07B19.19B17.90B19.16B17.40B
PP&E, netmay include right-of-use assets (IFRS)7.83B10.26B9.38B9.42B10.35B
Goodwill17.71B22.31B21.11B21.61B20.33B
Intangibles17.05B18.59B18.36B18.88B18.26B
Total assets70.47B79.75B75.27B77.82B75.09B
Current liabilities21.66B25.23B23.51B25.43B24.78B
Total liabilities52.88B57.20B54.50B56.12B55.35B
Shareholders' equity15.53B19.99B18.10B19.02B17.11B
Shares outstanding—2.48B2.50B2.53B—
Cash flow statement
Operating cash flow8.35B9.52B9.43B7.28B7.97B
Capital expenditure1.42B1.38B1.19B1.46B1.11B
Free cash flow6.93B8.14B8.23B5.83B6.86B
Investing cash flow-3.12B-625.00M-2.29B2.45B-3.25B
Financing cash flow-6.81B-6.94B-7.19B-8.89B-7.10B
Depreciation & amortization1.31B1.24B1.15B1.73B1.75B
Stock-based compensation255.00M292.00M192.00M177.00M161.00M
Dividends paid4.45B4.32B4.33B4.36B4.46B

Free plan shows the latest 5 periods; Pro shows all 11 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· Amounts are in the company's reporting currency, EUR, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.